Page 48 - 《中国药房》2023年24期
P. 48

LI S S,XU W,DU W W,et al. Study on the availability   [ 7 ]  马瑞娟,黄伟,段彦彦,等. 药品集中带量采购政策在儿
               of pediatric essential medicines in China:based on the sur‐  童专科医院实施现状:以某三甲儿童专科医院为例[J].
               veys  in  19  provinces[J].  Chin  J  Health  Policy,2018,11  儿科药学杂志,2023,29(6):19-22.
              (12):12-18.                                          MA R J,HUANG W,DUAN Y Y,et al. Implementation
          [ 2 ]  胡娅娅,江牧. 儿童药品包装设计中的修辞性叙事[J]. 包                     status of centralized drug quantity purchase policy in chil-
               装工程,2022,43(8):225-230,265.                         dren’s hospitals:taking a grade three,class A children’s
               HU  Y  Y,JIANG  M.  Rhetorical  narrative  in  children’s   hospital as an example[J]. J Pediatr Pharm,2023,29(6):
               drug packaging design[J]. Packag Eng,2022,43(8):225-  19-22.
               230,265.                                       [ 8 ]  张焕波,张岳洋,孙珮. 加快完善药品和医用耗材集中带
          [ 3 ]  陈哲,李思雨,李海龙,等. 四川省儿童用药品研发生产                        量采购制度[J]. 中国物价,2023(7):68-71.
               和使用现状调查[J]. 中国循证医学杂志,2023,23(5):                    ZHANG  H  B,ZHANG Y Y,SUN  P.  Speed  up  the  im‐
               497-503.                                            provement  of  the  volume-based  procurement  system  for
               CHEN Z,LI S Y,LI H L,et al. The development,produc‐  drugs and medical consumables[J]. China Price,2023(7):
               tion and use of medicine for children in Sichuan Province:  68-71.
               a across-sectional study[J]. Chin J Evid Based Med,2023,  [ 9 ]  汤少梁,朱亚,冯莉钧,等. 基于供给侧改革的我国儿童
               23(5):497-503.                                      用药安全性与可及性优化路径研究[J]. 中国医药导报,
          [ 4 ]  关玮伟,宋子扬,梅冬,等. 儿童医院口服药品分剂量现                        2017,14(35):125-129.
               状调查与分析[J]. 儿科药学杂志,2022,28(2):26-30.                 TANG  S  L,ZHU Y,FENG  L  J,et  al. The  optimization
               GUAN W W,SONG Z Y,MEI D,et al. Investigation and    path of safety and accessibility of pediatric drugs in China
               analysis on drug manipulation for pediatric oral dosing in   based  on  the  supply  side  reform  research[J].  China  Med
               pediatric  hospitals[J].  J  Pediatr  Pharm,2022,28(2):  Her,2017,14(35):125-129.
               26-30.                                         [10]  任延峰,杨毅,明坚,等 . 药品集中采购政策的 WHO 经
          [ 5 ]  曾卫强,王夏影,陈锦金,等. 某妇幼保健院口服片剂分                        验及启示[J]. 卫生经济研究,2022,39(6):17-19.
               剂量的现状及对策分析[J]. 广东药科大学学报,2022,38                     REN Y F,YANG Y,MING J,et al. Experience of WHO
              (6):25-30.                                           about  volume-based  drug  procurement  policy[J].  Health
               ZENG W Q,WANG X Y,CHEN J J,et al. Analysis of the   Econ Res,2022,39(6):17-19.
               current  situation  and  countermeasures  of  oral  tablet    [11]  张宸,凡馨,金秋晨,等. 日本儿童药定价及价格激励政
               subdosing  in  a  maternal  and  child  health  center[J].  J   策对我国的启示[J]. 中国药房,2021,32(23):2822-2827.
               Guangdong Pharm Univ,2022,38(6):25-30.              ZHANG C,FAN X,JIN Q C,et al. Pediatric drug pricing
          [ 6 ]  卫陈,顾海. 基于解释结构模型的儿童用药有效供给制                         and price incentive policy in Japan and its enlightenment
               约因素分析[J]. 中国全科医学,2015,18(31):3872-3875.             to China[J]. China Pharm,2021,32(23):2822-2827.
               WEI C,GU H. Restraining factors for the effective supply     (收稿日期:2023-07-01  修回日期:2023-10-23)
               of drug for children based on interpretative structural mo-                        (编辑:孙 冰)
               deling[J]. Chin Gen Pract,2015,18(31):3872-3875.

























          · 2986 ·    China Pharmacy  2023 Vol. 34  No. 24                            中国药房  2023年第34卷第24期
   43   44   45   46   47   48   49   50   51   52   53